As of 2026-03-19, the Intrinsic Value of Oncolytics Biotech Inc (ONC.TO) is -1.41 CAD. This ONC.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.42 CAD, the upside of Oncolytics Biotech Inc is -199.51%.
Based on its market price of 1.42 CAD and our intrinsic valuation, Oncolytics Biotech Inc (ONC.TO) is overvalued by 199.51%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.41 - -1.41 | -1.41 | -199.51% |
| P/E | (0.02) - (0.06) | (0.03) | -102.0% |
| DDM - Stable | (2.77) - (10.53) | (6.65) | -568.6% |
| DDM - Multi | (0.05) - (0.13) | (0.07) | -104.9% |
| Market Cap (mil) | 152.81 |
| Beta | 0.89 |
| Outstanding shares (mil) | 107.61 |
| Enterprise Value (mil) | 149.64 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.77% |
| Cost of Debt | 5.00% |
| WACC | 8.75% |